M-F esophagus(56)
_________________________________________________________________
mitomycin....... 10 mg/sqm IV day 1.
fluorouracil.... 1,000 mg/sqm/day continuous IV on days 1 to 4
and on days 29 to 32.
FREQUENCY....... This one cycle is usually followed by surgery
or radiation therapy.
reference...
Franklin R. Steiger Z. Vaishampayan G. Asfaw I. Rosenberg
J. Loh J. Hoschner J. Miller P. Combined modality therapy
for esophageal squamous cell carcinoma. Cancer.
51(6):1062-71, 1983 Mar 15.
abstract...
Of 55 patients with esophageal squamous cell carcinoma, 30
with localized disease were treated with a combined modality
for curative intent. Treatment consisted of mitomycin C (10
mg/m2 day 1) and continuous infusion 5-FU (1000 mg/m2 day,
days 1-4, 29-32) (CT), radiation (XRT) (3000 rad, days 1-21)
with nutritional support, and surgery (days 49-64). Surgery
consisted of celiotomy, esophagectomy and esophagogastrostomy
+/- postoperative ventilatory support. Postoperative CT plus
an additional 2000 rad XRT was restricted to patients with
histologic positive tumor. Since five resected patients with
subclinical metastatic tumor had an inferior survival equal to
25 patients treated essentially for palliation, pretreatment
celiotomy seems warranted to identify patients with an
inferior prognosis. Of 18 resected patients without
disseminated tumor evaluable for this combined modality: six
were tumor free, three had intramural and nine transmural
tumor; the median survival is 76 weeks and five of six living
patients are disease free at 95-190 weeks; and local
recurrence occurred in two and in two of seven unresected
patients. Since toxicity was minimal except for postoperative
pneumonitis (13%) and local recurrence low (13%), two courses
of chemotherapy and 5000 rad XRT perhaps obviates the need for
resection.
|